Market Overview

Sucampo to be Added to NASDAQ Biotechnology Index

Related SCMP
Mid-Morning Market Update: Markets Edge Higher; Staples Earnings Miss Views
Mid-Afternoon Market Update: Dow Falls 50 Points; H & R Block Shares Spike Higher
Adams Express Co Buys Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Johnson & ... (GuruFocus)

Sucampo Pharmaceuticals (NASDAQ: SCMP) (SPI) today announced that
NASDAQ OMX Group, Inc. (NASDAQ: NDAQ) will include the company in the
NASDAQ Biotechnology Index® (NASDAQ: NBI) effective prior to
market open on Monday, May 20, 2013.

The NASDAQ Biotechnology Index is designed to track the performance of a
set of securities listed on The NASDAQ Stock Market that are classified
as either biotechnology or pharmaceutical according to the Industry
Classification Benchmark (ICB). The NASDAQ Biotechnology Index is a
modified market capitalization weighted index. Among the various
criteria that must be met in order to be eligible for inclusion in this
index are a market capitalization of at least $200 million and an
average daily trading

See full press release

Posted-In: Earnings News Guidance Contracts Management Global


Related Articles (NDAQ + SCMP)

View Comments and Join the Discussion!